Clinical Trial

Cost Profile and Budget Implications of Rechargeable Versus Non-rechargeable Sacral Neuromodulation Devices for Neurogenic Lower Urinary Tract Dysfunction

Study acronym: SNM、NLUTD
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 15, 2025 (before its estimated April 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
Traditional sacral neuromodulation devices are not rechargeable. In recent years, new rechargeable sacral neuromodulation devices have been developed and put into the market. The aim of this study was to evaluate the cost savings of a rechargeable sacral neuromodulation device versus a non-rechargeable sacral neuromodulation device for the treatment of neurogenic lower urinary tract dysfunction.
Trial Details
NCT Number NCT07173517
Lead Sponsor Qilu Hospital of Shandong University
Collaborators: Aerospace Center Hospital, Shandong Provincial Hospital, Second Affiliated Hospital of Xi'an Jiaotong University, Beijing Hospital, Xi'an Honghui Hospital, The First Affiliated Hospital of Zhengzhou University, Second Hospital of Jilin University, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, Tongji Hospital
Conditions Rechargeable Sacral Neuromodulation Device, Neurogenic Lower Urinary Tract Dysfunction
Enrollment 268 participants
Start Date 2025-10-01
Primary Completion 2026-04-30 (estimated)
Study Completion 2026-04-30 (estimated)
Updated on ClinicalTrials.gov 2025-09-15